Autolus Therapeutics plc (AUTL)
Latest AUTL Insider Trades
- William D. Young - DirectorGrant or award31,667 sh
- William D. Young - DirectorGrant or award47,500 sh
Madduri Ravin Rao - DirectorGrant or award
About Autolus Therapeutics plc (AUTL)
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.
- LONDON, X0
- 752
- 2018
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 18 | 712,503 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
AUTL Insider Transactions (Form 4)
189 Form 4 filings on record, the earliest from Jul 1, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| William D. Young - Director | Grant or award | Restricted Share Units | 31,667 |
Recent AUTL Form 8-K Filings
3AUTL Insider Trading - FAQ
What is the latest insider trade for AUTL?
Autolus Therapeutics plc (AUTL) had 9 insider filings in the last 90 days, with the most recent on 2026-07-01. The full record for AUTL runs to 9 Form 4 filings, the earliest from 2026-07-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AUTL stock?
No insider purchases of AUTL were filed in the last 90 days.
How many insiders are selling AUTL stock?
No insider sales of AUTL were filed in the last 90 days.
Where can I see AUTL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks AUTL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AUTL insider buys?
Create a free InsiderAlpha account and press Watch on this page to add AUTL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Companies with Insider Activity
Recent Insider Filings
9Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - William D. Young view on EDGAR
- - Madduri Ravin Rao view on EDGAR
- - Ryan Richardson view on EDGAR
- - Elisabeth Leiderman view on EDGAR
- - Robert Iannone view on EDGAR
- - Cynthia M. Butitta view on EDGAR
- - Linda Bain view on EDGAR
- - Robert Azelby view on EDGAR
- - Michael W. Bonney view on EDGAR
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity by sector
- Where buying and selling is concentrated across the eleven GICS sectors.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track AUTL insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
